MMP14 and gastric cancer: Moreover, treatment with GSK343 and A-366 prevented the gastric cancer cells from increased enrichment of H3K27me3 and H3K9me2 and decreased binding of YY1 to MMP-14 promoter induced by miR-584-3p over-expression (Supplementary Fig. S2f).